• Did we need to reinvent the wheel? Why Share4Rare adopted a layered approach to user interaction

    It was one year ago, in the summer of 2018, when I attended my first meeting of the Consortium of the Share4Rare project . The project had been going on for a while and the foundations were laid, but
  • Understanding the Sturge-Weber syndrome

    The Sturge-Weber syndrome is characterized by the deficient development of certain blood vessels, leading to structural abnormalities; especially in the brain, skin and eyes. Three features are
  • Lluís Montoliu: "Patients have taught me everything I know"

    Lluís Montoliu is a pioneer in the introduction, use and dissemination of CRISPR technology in Spain. Author of more than a hundred scientific articles, he has been involved in the field of biomedical
  • Safe motherhood in rare disease

    " Duchenne muscular dystrophy is a genetic disorder characterized by the progressive loss of muscle . Duchenne is caused by a mutation in the gene that encodes for dystrophin , a protein that is
  • Intrinsic motivation with a pinch of salt: the conceptualization of badges in Share4Rare

    If you have ever attended a talk on the topic of gamification, you will have noticed that a concept is on everyone’s lips: motivation . And rightly so: it is one of the cornerstones to understanding
  • Markel’s story: the uncertainty of living without a diagnosis

    Markel lives with his parents, María and Vicen, and his older sister Carlota in Urnieta, a small town near San Sebastián, Basque Country (Spain). He will become 13 in August, but he looks much younger
  • Share4Rare: a unique community of patients that you would never have imagined

    One of the greatest challenges that rare disease patients and families have to face is the feeling of loneliness . This emotion is present during the diagnostic process — which may last for years —
  • Inflammatory myofibroblastic tumors: treatments and research

    Because of the low index of metastasis in inflammatory myofibroblastic tumours (IMTs), surgery is normally the preferred and best option. The surgical resection of the tumour can be definite and
  • What are inflammatory myofibroblastic tumors?

    Inflammatory myofibroblastic tumors are more commonly referred to as IMTs . Their name comes after two different types of cells: “Myo” comes from the greek term “ Myos ”, which means muscle, and
  • Can children get melanoma?

    Skin melanoma in children is very rare: out of 1.1 million children under the age of 4, less than 1 will be diagnosed with melanoma. For children under the age of 10, the number of melanoma cases has
  • What is infantile myofibromatosis?

    Infantile myofibromatosis (IM) is a rare benign soft tissue tumor, meaning it can grow wherever there is soft tissue – this includes many tissues in our body, the most prevalent areas are the skin and
  • RareHacks: open registration!

    The access of rare disease families to quality , curated information about a particular disease is difficult due to many factors, including data gathering, curation, quality or unbiased interpretation